ANTI-B1 MONOCLONAL ANTIBODY AND COMPLEMENT TREATMENT IN AUTOLOGOUS BONE-MARROW TRANSPLANTATION FOR RELAPSED B-CELL NON-HODGKIN'S LYMPHOMA
- 1 August 1984
- journal article
- research article
- Published by Elsevier in The Lancet
- Vol. 324 (8400), 427-431
- https://doi.org/10.1016/s0140-6736(84)92907-6
Abstract
No abstract availableThis publication has 27 references indexed in Scilit:
- ROLE OF MASSIVE CHEMOTHERAPY AND AUTOLOGOUS BONE-MARROW TRANSPLANTATION IN NON-HODGKIN'S MALIGNANT LYMPHOMAThe Lancet, 1984
- Review of the use of marrow transplantation in the treatment of non-Hodgkin's lymphoma.Journal of Clinical Oncology, 1983
- Treatment of non-Hodgkin's lymphoma with marrow transplantation in identical twinsBlood, 1981
- High dose chemotherapy and autologous bone marrow transplantation in acute leukemias, malignant lymphomas and solid tumorsEuropean Journal of Cancer (1965), 1981
- No Initial Therapy for Stage III and IV Non-Hodgkin's Lymphomas of Favorable Histologic TypesAnnals of Internal Medicine, 1979
- Successful engraftment of cryopreserved autologous bone marrow in patients with malignant lymphomaBlood, 1978
- Sequential pathologic staging of untreated non-Hodgkin's lymphomas by laparoscopy and laparotomy combined with marrow biopsyCancer, 1977
- Frequencies and patterns of bone marrow involvement in non‐hodgkin lymphomas: Observations on the value of bilateral biopsiesAmerican Journal of Hematology, 1977
- Sequential Nonsurgical and Surgical Staging of Non-Hodgkin's LymphomaAnnals of Internal Medicine, 1976
- Incidence, cytology, and histopathology of non-Hodgkin's lymphomas in the bone marrowCancer, 1974